Oncology CME

Credits: 1.00 CME
Medical Learning Institute, Inc.
Progress and Promise With Immunotherapy in Resectable Melanoma: Exploring New Evidence and Practical Issues With Checkpoint Inhibitors as Adjuvant Therapy
25 April, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Addressing Unmet Needs in Earlier Stages of NSCLC With Immunotherapy: Cutting-Edge Research, Clinical Applications, and Practical Challenges
15 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapeutic Concepts for ASCT-Eligible Patients With Myeloma: Advancing Toward More Effective Care Across Treatment Settings
10 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Attacking the Clinical Problem of VOD/SOS in HCT Recipients: Insights on Pathophysiology, Diagnosis, and Treatment
3 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Harnessing Recent Advances in CAR-T Cell Therapy for Leukemia and Lymphoma in the Era of Stem Cell Transplantation
2 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Integrating Innovative Therapeutics With Allogeneic HCT in AML: Insights and Evidence From Induction to Maintenance
29 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapies in Post-Transplant GVHD: Personal Insights From the Patient CaseBook
28 March, 2019
Credits: 1.50 CME
Purdue University College of Pharmacy
Unraveling the Complexities of Prostate Cancer Management: Focus on Therapeutic Decisions for Early-Stage Disease and the Implications for Later-Stage Disease
26 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Managing CMV in the New Era of Antiviral Therapy: Practical Considerations in the HCT Setting
26 March, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making Effective Therapeutic Choices for Advanced RCC in an Evolving Treatment Landscape: Personal Insights From the Patient CaseBook
20 March, 2019
Credits: 0.50 CME
University of Nebraska Medical Center
Exploring Clinical Decisions in the New Era of Myeloma Management: The Impact of Novel Platforms and Agent Classes Across the Spectrum of Care
13 March, 2019
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Urgent Care of Patients Receiving Cancer Immunotherapy: Recognition and Management of Immune-Mediated Adverse Reactions in the ED
22 February, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Breaking the Paradox: Expanding Options and New Questions in HCC Management—Mapping the Pathways to Better Patient Outcomes
15 February, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Building Innovative Treatment Options for Patients With B-Cell Malignancies: Practical Insights on Clinical Evidence and Integration Strategies
15 February, 2019
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy
7 February, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Progress in Developing Novel Treatment Options for PTCL: Expert Views on Integrating Innovative Therapeutics Into Care
29 January, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes
31 December, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Promise of New Concepts and Innovative Therapy in Advanced Sarcoma: From Established Targets to TRK Inhibition and Beyond
27 December, 2018
Credits: 0.75 CME / MOC / CNE
Medical Learning Institute, Inc.
The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care
5 December, 2018

Pages